IFNG and relapsing-remitting multiple sclerosis: Th17 cells can switch to a Th1-like phenotype, which releases IFN-γ and IL-17, detectable in brain tissue, CSF, and peripheral circulation of RRMS patients in the relapse phase (20–22).